| 2021 | Nanocomplex‐Mediated In Vivo Programming to Chimeric Antigen Receptor‐M1 Macrophages for Cancer Therapy Advanced Materials | 김병수, 현택환 | 219 |
| 2021 | T‐Cell‐Derived Nanovesicles for Cancer Immunotherapy Advanced Materials | 김병수 | 75 |
| 2021 | Nanovesicle‐Mediated Targeted Delivery of Immune Checkpoint Blockades to Potentiate Therapeutic Efficacy and Prevent Side Effects Advanced Materials | 김병수 | 57 |
| 2024 | Engineered Nanoparticles for Enhanced Antitumoral Synergy Between Macrophages and T Cells in the Tumor Microenvironment Advanced Materials | 김병수 | 31 |
| 2022 | Targeting TCTP sensitizes tumor to T cell-mediated therapy by reversing immune-refractory phenotypes Nature Communications | 정상택 | 19 |
| 2024 | Strategies to Overcome Hurdles in Cancer Immunotherapy Biomaterials Research | 김병수 | 18 |
| 2021 | Microfluidic valvular chips and a numerical lymphatic vessel model for the study of lymph transport characteristics 화학공정 › 공정시스템기술 Lab on a Chip | 김정욱 | 10 |
| 2023 | Glycan-Controlled Human PD-1 Variants Displaying Broad-Spectrum High Binding to PD-1 Ligands Potentiate T Cell Molecular Pharmaceutics | 정상택 | 3 |
| 2025 | Directed evolution–driven reprogramming of PD-L1 for compact and tunable checkpoint modulation Journal of Biological Engineering | 정상택 | 1 |
| 2025 | Directed evolution and modular integration of a high-affinity ICOS-L variant for potent T cell–mediated tumor elimination Journal of Biological Engineering | 정상택 | 0 |